Effect of olfactory bulb pathology on olfactory function in normal aging

Decline of olfactory function is frequently observed in aging and is an early symptom of neurodegenerative diseases. As the olfactory bulb (OB) is one of the first regions involved by pathology and may represent an early disease stage, we specifically aimed to evaluate the contribution of OB patholo...

Full description

Saved in:
Bibliographic Details
Published in:Brain pathology (Zurich, Switzerland) Switzerland), 2022-09, Vol.32 (5), p.e13075-n/a
Main Authors: Tremblay, Cécilia, Serrano, Geidy E., Intorcia, Anthony J., Sue, Lucia I., Wilson, Jeffrey R., Adler, Charles H., Shill, Holly A., Driver‐Dunckley, Erika, Mehta, Shyamal H., Beach, Thomas G.
Format: Article
Language:English
Subjects:
Age
Aged
Aging
alpha-Synuclein - metabolism
Alzheimer Disease - pathology
Alzheimer's disease
Amyloid
Amyloid beta-Peptides - metabolism
amyloid β
Autopsies
Autopsy
Basal ganglia
Brain
Central nervous system diseases
Dementia
Dementia disorders
Humans
Letter to the Editor
Letters to the Editor
Lewy body disease
Medical research
Medicine, Experimental
Movement disorders
Nervous system diseases
Neurodegenerative diseases
Olfaction
Olfactory bulb
Olfactory Bulb - metabolism
Olfactory discrimination
Parkinson's disease
Pathology
Performance prediction
Smell
Synuclein
tau
Tau protein
tau Proteins - metabolism
α‐synuclein
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Decline of olfactory function is frequently observed in aging and is an early symptom of neurodegenerative diseases. As the olfactory bulb (OB) is one of the first regions involved by pathology and may represent an early disease stage, we specifically aimed to evaluate the contribution of OB pathology to olfactory decline in cognitively normal aged individuals without parkinsonism or dementia. This clinicopathological study correlates OB tau, amyloid β (Aβ) and α‐synuclein (αSyn) pathology densities and whole brain pathology load to olfactory identification function as measured with the University of Pennsylvania Smell Identification Test (UPSIT) and clinical data measured proximate to death in a large autopsy study including 138 cases considered non‐demented controls during life. Tau pathology was frequently observed in the OB (95% of cases), while both Aβ (27% of cases) and αSyn (20% of cases) OB pathologies were less commonly observed. A weak correlation was only observed between OB tau and olfactory performance, but when controlled for age, neither OB tau, Aβ or αSyn significantly predict olfactory performance. Moreover, whole brain tau and αSyn pathology loads predicted olfactory performance; however, only αSyn pathology loads survived age correction. In conclusion, OB tau pathology is frequently observed in normally aging individuals and increases with age but does not appear to independently contribute to age‐related olfactory impairment suggesting that further involvement of the brain seems necessary to contribute to age‐related olfactory decline. Findings of this clinicopathological correlative study suggest that olfactory bulb pathology is frequently observed in normally aging individuals and increases with age but does not appear to independently contribute to age‐related olfactory impairment.
ISSN:1015-6305
1750-3639
DOI:10.1111/bpa.13075